what does glp 1 stand for is GLP-1 & it Affect Weight & Cognition? The promise and peril of
Description
A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases
The GLP-1 boom is making people desperate to get the pricey weight-loss drugs
however, they can also lead to nutrient depletion
The long-term business implications could be massive
As a result, they are effective treatment options for people with T2D, achieving glycated haemoglobin reductions, weight loss and potential cardiovascular benefit, as monotherapy or as add-on to other glucose-lowering therapies
